Study guide
4.4 Blood Sampling Technique, Specimen Handling, and Point-of-Care Testing
Certified Clinical Hemodialysis Technician — Advanced CCHT-A
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: CCHT-A Examination Blueprint and Advanced Technician Scope
1.1 CCHT-A Blueprint, Eligibility, Scoring, and Test-Day Logistics 1.2 Application-Level Reasoning and the CCHT to CCHT-A Scope Step-Up
2 Chapter 2: Renal Anatomy, Pathophysiology, and Dialysis Principles
2.1 Renal Anatomy, Physiology, and AKI vs. CKD Progression 2.2 Principles of Solute and Fluid Transport: Diffusion, Convection, Osmosis, and Ultrafiltration 2.3 Dialysate Composition, Acid-Base Balance, and Electrolyte Dynamics 2.4 Mineral and Bone Disorder (MBD), Anemia Management, and Endocrine Functions
3 Chapter 3: Fluid Dynamics, Volume Assessment, and Kinetic Modeling
3.1 Estimated Dry Weight (EDW), Volume Overload, and Clinical Fluid Assessment 3.2 Ultrafiltration Rate (UFR) Calculations, Safety Thresholds, and Myocardial Stunning 3.3 Urea Kinetic Modeling: Kt/V Targets, URR Calculations, and Adequacy Optimization 3.4 Residual Kidney Function, Incremental Hemodialysis, and Adequacy Beyond Kt/V
4 Chapter 4: Pre-Treatment Assessment, Laboratory Monitoring, and Clinical Evaluation
4.1 Pre-Dialysis Clinical Assessment, Vital Signs, and Nurse Notification Criteria 4.2 Laboratory Monitoring, Electrolyte Trends, and Critical Value Management 4.3 Extracorporeal Anticoagulation: Heparin Protocols, Monitoring, and Heparin-Free Dialysis 4.4 Blood Sampling Technique, Specimen Handling, and Point-of-Care Testing
5 Chapter 5: Advanced Vascular Access Management
5.1 Vascular Access Types: AV Fistulas, AV Grafts, Tunneled CVCs, and KDOQI Guidelines 5.2 Physical Examination of Vascular Access: Look, Listen, Feel, and Flow Dysfunction 5.3 Advanced Cannulation Practice: Rope-Ladder, Buttonhole Technique, and Needle Geometry 5.4 Access Complications: Infiltration, Stenosis, Thrombosis, Bleeding, and Recirculation 5.5 Central Venous Catheter Management: Connection, Locking, Termination, and CLABSI Prevention
6 Chapter 6: Treatment Delivery: Prescription, Initiation, and Ancillary Support
6.1 Dialysis Prescription Interpretation and Machine Programming 6.2 Treatment Initiation: Line Connection, Prime Management, and Blood Pump Ramp-Up 6.3 Oxygen Administration, Topical and Local Anesthetics, and Ancillary Equipment Monitoring
7 Chapter 7: Intradialytic Monitoring, Complications, and Medical Emergencies
7.1 Intradialytic Hypotension (IDH), Fluid Shifts, and Muscle Cramping Protocols 7.2 Dialysis Disequilibrium Syndrome (DDS), Endotoxin Infusion, and Pyrogen Reactions 7.3 Critical Circuit Emergencies: Air Embolism, Hemolysis, and Venous Needle Dislodgement 7.4 Post-Treatment Evaluation, Hemostasis Management, and Discharge Safety 7.5 Medical Emergencies, Cardiac Arrest Response, and the Technician's Resuscitation Role
8 Chapter 8: Dialysis Machine Mechanics, Concentrates, Alarms, and Troubleshooting
8.1 Extracorporeal Circuit Assembly, Saline Priming, and Microbubble Removal 8.2 Pressure Sensor Dynamics: Arterial Pressure, Venous Pressure, TMP, and Safety Alarms 8.3 Dialysis Machine Testing, Independent Conductivity/pH Verification, and Disinfection 8.4 Concentrate Systems: Acid and Bicarbonate Mixing, Powder Cartridges, and Central Delivery 8.5 Equipment Quality Control, Machine Bypass, and Troubleshooting Escalation
9 Chapter 9: Water Treatment Systems, AAMI/ISO Standards, and Facility Operations
9.1 Water Pre-Treatment: Backflow Preventers, Multimedia Filters, Softeners, and Brine Tanks 9.2 Carbon Adsorption Beds, EBCT, Chlorine/Chloramine Testing, and Breakthrough Protocols 9.3 Reverse Osmosis (RO) Mechanics, Membrane Performance, Deionization (DI), and Ultrafilters 9.4 AAMI/ISO Water & Dialysate Microbial Standards, Action Levels, and Colony Counting 9.5 Facility and Water System Start-Up, Daily Monitoring Logs, and End-of-Day Shutdown
10 Chapter 10: Infection Control, Environmental Safety, and Emergency Preparedness
10.1 CDC Dialysis Precautions, Hand Hygiene, and Station Clean/Dirty Boundary Discipline 10.2 Hepatitis B Isolation Requirements, Serologic Monitoring, HCV, and HIV Precautions 10.3 Environmental Surface Disinfection, Bleach Protocols, Chemical Spills, and Emergency Operations 10.4 Life Safety Code, Fire Response, Emergency Evacuation, and Disaster Preparedness 10.5 Safe Patient Transfers, Body Mechanics, Falls Prevention, and Intradialytic Exercise 10.6 Maintaining a Therapeutic Environment: Noise, Temperature, Lighting, and Comfort
11 Chapter 11: Quality Improvement, CMS Regulations, Documentation, and Patient Rights
11.1 CMS Conditions for Coverage (42 CFR Part 494), Technician Scope, and Survey Readiness 11.2 ESRD Quality Incentive Program (QIP), NHSN Measures, and Clinical Outcome Scoring 11.3 Medical-Legal Documentation Standards, EHR Integrity, Root Cause Analysis, and Incident Reporting 11.4 Patient Privacy, Confidentiality, and Dignity on an Open Treatment Floor 11.5 Unit-Based Cannulation Teams, In-Service Education, and QAPI Participation
12 Chapter 12: Advanced Professional Practice, Preceptorship, Communication, and Advocacy
12.1 Clinical Preceptorship, Adult Learning Principles, Competency Assessment, and Safety Culture 12.2 Patient Education, Health Literacy, Fluid/Diet Adherence, and Modality Exploration 12.3 Professional Ethics, Interdisciplinary Collaboration, and Boundary Maintenance 12.4 Shift Handoff, Break Coverage, and Differentiating Care-Team Roles 12.5 Recognizing Escalating Behavior, De-escalation, Restraints, and Involuntary Discharge 12.6 Cultural Diversity, Language Access, and Patient-Centered Communication
4.4 Blood Sampling Technique, Specimen Handling, and Point-of-Care Testing
Key Takeaways Explain This Topic AI
Pre-dialysis blood samples are drawn from the arterial needle or arterial line before heparin administration and before any saline infusion; drawing after heparin or into a saline-diluted line invalidates the specimen.
When a central venous catheter is the access, the lock solution must be aspirated and discarded, typically 3 to 6 mL or the volume printed on the catheter hub, before any sample is drawn; flushing the lock into the patient risks a heparin bolus or citrate-induced hypocalcemia.
The KDOQI slow-flow post-dialysis blood urea nitrogen method requires turning ultrafiltration to zero, placing dialysate in bypass, reducing the blood pump to 50 to 100 mL/min for 15 to 20 seconds, and then drawing from the arterial sample port before rinse-back.
Point-of-care glucose meters and reagent test strips require documented quality-control testing at defined intervals with in-date reagents; a meter that fails control ranges must be removed from service, not used with a mental correction factor.
Specimen tubes are filled in the correct order of draw, inverted gently the specified number of times rather than shaken, labeled at the chairside in the presence of the patient with two identifiers, and transported per facility policy.
Last updated: September 2026
4.4 Blood Sampling Technique, Specimen Handling, and Point-of-Care Testing
Quick Summary: A perfect laboratory instrument cannot rescue a badly drawn specimen. The advanced technician controls the three variables that decide whether a result is real: when in the treatment the sample is taken, where in the circuit it is taken from, and how the tube is filled, mixed, labeled, and transported.
Pre-Dialysis Sampling
Monthly laboratories - urea nitrogen, creatinine, electrolytes, calcium, phosphorus, intact parathyroid hormone, albumin, hemoglobin, ferritin, and transferrin saturation - describe the patient's steady state and must be drawn before anything in the circuit alters them.
Rules for a valid pre-dialysis draw:
Before heparin. Heparin does not change urea, but it invalidates coagulation studies and can interfere with selected assays. The universal teaching point is that the pre-dialysis specimen is obtained prior to the heparin bolus .
Before saline. Any saline infusion, including the residual prime, dilutes the sample. Draw from the arterial needle or arterial line before the blood pump is started , or immediately after connection before saline is delivered.
From the arterial side. The arterial needle carries blood coming from the patient. A venous-side pre-draw during running dialysis returns a dialyzed specimen.
Discard volume. Follow facility policy for the initial discard aliquot when drawing through a line with a residual saline column.
Sampling Through a Central Venous Catheter
Catheters are filled at the end of every treatment with a lock solution - concentrated heparin (typically 1,000 to 5,000 units/mL), 4% sodium citrate, or an alternative antimicrobial lock - that occupies the internal volume printed on each hub, generally 1.3 to 3.0 mL per lumen.
The rule is absolute: aspirate the lock and discard it before drawing any sample or initiating treatment. Aspirate the labeled priming volume plus a margin, generally 3 to 6 mL, into a syringe and discard it into a designated receptacle.
Action with the lock Consequence
Aspirate and discard (correct) Removes concentrated anticoagulant; the sample that follows reflects patient blood
Flush the lock into the patient Systemic heparin bolus with bleeding risk, or citrate-induced acute hypocalcemia with perioral tingling, tetany, and arrhythmia
- Draw the sample without aspirating Specimen is heparin- or citrate-contaminated and unusable
- Flush with saline, then draw immediately Dilutes the specimen and produces falsely low results
Never force an occluded catheter. Excessive pressure can fracture the catheter or dislodge a thrombus. Report resistance to the nurse; declotting with a thrombolytic is a nursing or physician function.
The Post-Dialysis Blood Urea Nitrogen
The post-dialysis urea sample decides both URR and Kt/V, and it is the specimen most often drawn incorrectly. Two effects corrupt it:
Access recirculation - dialyzed blood re-entering the arterial needle - yields a falsely low post-BUN and a falsely inflated Kt/V.
Compartmental (solvent) rebound - urea moving out of tissue back into blood over 30 to 60 minutes after treatment ends.
KDOQI slow-flow method:
At the end of the prescribed treatment time, set the ultrafiltration rate to zero .
Place the dialysate in bypass (or turn dialysate flow off) so no further diffusive clearance occurs.
Reduce the blood pump to 50-100 mL/min and wait 15-20 seconds. This clears the recirculated blood from the arterial needle without allowing meaningful rebound.
Draw the sample from the arterial sample port - before rinse-back, before saline.
Stop the pump, then complete rinse-back and termination normally.
Drawing after saline rinse-back, or drawing at full blood flow with dialysate running, is the classic error. A pair of laboratories showing an implausible jump in Kt/V should always raise the question of sampling technique before anyone congratulates the prescription.
Order of Draw and Tube Handling
When multiple tubes are filled from one draw, additive carryover between tubes changes results. The standard sequence:
- Order Tube stopper Additive Typical dialysis use
- 1 Blood culture bottles Broth Suspected catheter-related bloodstream infection
- 2 Light blue Sodium citrate Coagulation studies
- 3 Red or gold (serum) Clot activator / gel Chemistry, iron studies, parathyroid hormone
- 4 Green Heparin Selected chemistries
- 5 Lavender EDTA Hemoglobin, hematocrit, complete blood count
- 6 Gray Sodium fluoride Glucose
Additional handling rules:
Invert gently the number of times the manufacturer specifies - typically 8 to 10 for additive tubes. Shaking causes hemolysis , which falsely elevates potassium and invalidates the specimen.
Fill citrate tubes completely. An underfilled blue-top has the wrong blood-to-anticoagulant ratio and produces falsely prolonged clotting times.
Label at the chairside, in the patient's presence, before leaving the station , using two patient identifiers. Pre-labeling tubes at the nurses' station and labeling later are both mislabeling events waiting to happen; a mislabeled specimen is a reportable adverse occurrence.
Transport per policy - refrigerated, on ice, or protected from light where required, and within the stated stability window.
Point-of-Care Testing and Quality Control
Advanced technicians run several point-of-care devices, and each has a quality-control obligation the CCHT-A blueprint names explicitly.
Blood glucose meters. Diabetes is the leading cause of end-stage kidney disease, and hypoglycemia during dialysis is common because glucose crosses the membrane. Obtain a glucose whenever a patient becomes diaphoretic, tremulous, confused, or unexpectedly hypotensive, and whenever protocol directs. Controls at two levels must be run at the interval facility policy specifies - typically each day of use and with each new lot or new operator - and results logged. A meter reading outside the control range is removed from service ; it is never used with a mental correction.
Reagent test strips and colorimeters for total chlorine, water hardness, and residual germicide follow the same discipline: strips within the printed expiration date, stored capped and dry, timed exactly as the manufacturer instructs, read against the correct scale, and documented. An expired or moisture-damaged strip can read a safe 0.00 ppm while lethal chloramine passes into the dialysate.
Hematocrit and hemoglobin devices used at the chairside require the same lot-specific controls and documented operator competency.
Every point-of-care result belongs in the treatment record with the value, the time, the device identifier, and the action taken. A glucose of 47 mg/dL that never reaches the nurse and never reaches the chart is, from a survey standpoint, a result that did not happen.